Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer
NCT00901342
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
104
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
BIOLOGICAL:
sipuleucel-T
Sponsor
Dendreon